![](/img/cover-not-exists.png)
Alkynylnicotinamide-based compounds as ABL1 inhibitors with potent activities against drug-resistant CML harboring ABL1(T315I) mutant kinase.
Sintim, Herman O., Larocque, Elizabeth, Naganna, N, Opoku-Temeng, Clement, Lambrecht, AlyssaLanguage:
english
Journal:
ChemMedChem
DOI:
10.1002/cmdc.201700829
Date:
April, 2018
File:
PDF, 1.67 MB
english, 2018